Ecolab reported strong first quarter 2025 results, delivering 12% growth in adjusted diluted EPS to $1.50. This performance was driven by effective value pricing, volume gains, and productivity improvements, which offset softening in certain end markets. Reported sales declined 2% to $3.7 billion, reflecting a 2% drag each from divestitures and currency effects, though organic sales rose 3%, led by Institutional & Specialty, Pest Elimination, and Life Sciences.

The company reported an operating income margin of 15.0%, with the organic margin rising 190 basis points to 16.0%. Despite a 1% decline in reported EPS to $1.41, Ecolab maintained its full-year 2025 adjusted EPS guidance of $7.42 to $7.62 (+12% to 15%) and expects Q2 adjusted EPS of $1.84 to $1.94 (+10% to 15%), citing continued pricing strength, business wins, and productivity gains.